Answers are grounded in this paper and cite their sources.
Personalized dosimetry has transformed yttrium 90 transarterial radioembolization from an empirically dosed palliative therapy into a precise potentially curative treatment, and treatment intent is the organizing principle that determines the dosimetry model, target dose, and normal tissue constraints for each clinical scenario, with improved tumor response and survival when therapeutic dose thresholds are achieved.
No takes yet. Share an insight, caveat, or question.
Nadeem et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: